BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 28618844)

  • 41. Superior Vena Cava Obstruction Complicated by Upper Extremity Deep Vein Thrombosis: A Novel Endovascular Approach.
    Khalifa M; Patel N; Moser S
    Vasc Endovascular Surg; 2016 Apr; 50(3):180-2. PubMed ID: 27036674
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Treatment of superior vena cava syndrome in cancer patients with intravascular stent and local thrombolysis].
    Zhang F; Wu P; Huang J
    Zhonghua Zhong Liu Za Zhi; 2000 Nov; 22(6):507-9. PubMed ID: 11235576
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stent placement for the treatment of malignant superior vena cava syndrome - a single-center series of 56 patients.
    Sobrinho G; Aguiar P
    Arch Bronconeumol; 2014 Apr; 50(4):135-40. PubMed ID: 24360084
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Review of Open and Endovascular Treatment of Superior Vena Cava Syndrome of Benign Aetiology.
    Sfyroeras GS; Antonopoulos CN; Mantas G; Moulakakis KG; Kakisis JD; Brountzos E; Lattimer CR; Geroulakos G
    Eur J Vasc Endovasc Surg; 2017 Feb; 53(2):238-254. PubMed ID: 28007450
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intravascular and hybrid intraoperative stent placement for baffle obstruction in transposition of the great arteries after atrial switch.
    Poterucha JT; Taggart NW; Johnson JN; Cannon BC; Cabalka AK; Hagler DJ; Dearani JA; Cetta F
    Catheter Cardiovasc Interv; 2017 Feb; 89(2):306-314. PubMed ID: 27785879
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of stent placement for vena cava syndrome: phase II trial and phase III randomized controlled trial.
    Takeuchi Y; Arai Y; Sone M; Sugawara S; Aramaki T; Sato R; Kichikawa K; Tanaka T; Morishita H; Ito T; Yamakado K; Baba Y; Kobayashi T
    Support Care Cancer; 2019 Mar; 27(3):1081-1088. PubMed ID: 30112721
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Safety and Efficacy of Stent Graft Implantation for Malignant Superior Vena Cava Syndrome.
    Cao S; Zou Y; Lyu T; Fan Z; Guan H; Song L; Tong X; Wang J
    Heart Surg Forum; 2021 Nov; 24(6):E952-E957. PubMed ID: 34962478
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Safety and Effectiveness of Abre Self-Expanding Venous Stent for Treatment of Superior Vena Cava Syndrome.
    An TJ; McNamara SL; Ardestani A; Zurkiya O; Cahalane A; Stecker MS; Epelboym Y; Burch E; Desai K; Kalva SP
    Vasc Endovascular Surg; 2024 Aug; 58(6):617-622. PubMed ID: 38670555
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Doppler superior vena cava flow evolution and respiratory variation in superior vena cava syndrome.
    Lv FQ; Duan YY; Yuan LJ; Wang W; Cao TS; Liu X
    Echocardiography; 2008 Apr; 25(4):360-5. PubMed ID: 18366353
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Percutaneous stenting of superior vena cava syndrome: a case report and review of the literature.
    Hochrein J; Bashore TM; O'Laughlin MP; Harrison JK
    Am J Med; 1998 Jan; 104(1):78-84. PubMed ID: 9528723
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Gianturco expandable metallic stents in the treatment of superior vena cava syndrome caused by lung cancer].
    Morita R; Akaogi E; Mitsui K; Kuramoto K; Onizuka M; Ishikawa S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Jun; 30(6):1110-5. PubMed ID: 1324377
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Endovascular stenting as a first choice for the palliation of superior vena cava syndrome.
    Kim YI; Kim KS; Ko YC; Park CM; Lim SC; Kim YC; Park KO; Yoon W; Kim YH; Kim JK; Ahn SJ
    J Korean Med Sci; 2004 Aug; 19(4):519-22. PubMed ID: 15308841
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Is Long-Term Anticoagulation Required after Stent Placement for Benign Superior Vena Cava Syndrome?
    Haddad MM; Thompson SM; McPhail IR; Bendel EC; Kalra M; Stockland AH; Neidert NB; Andrews JC; Misra S; Bjarnason H; Neisen MJ
    J Vasc Interv Radiol; 2018 Dec; 29(12):1741-1747. PubMed ID: 30396845
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Malignant Superior Vena Cava Syndrome: A Scoping Review.
    Wright K; Digby GC; Gyawali B; Jad R; Menard A; Moraes FY; Wijeratne DT
    J Thorac Oncol; 2023 Oct; 18(10):1268-1276. PubMed ID: 37146753
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rapid Fire: Superior Vena Cava Syndrome.
    Zimmerman S; Davis M
    Emerg Med Clin North Am; 2018 Aug; 36(3):577-584. PubMed ID: 30037444
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Superior vena cava syndrome: endovascular management.
    Karakhanian WK; Karakhanian WZ; Belczak SQ
    J Vasc Bras; 2019 Sep; 18():e20180062. PubMed ID: 31616492
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Stenting for superior vena cava obstruction in pediatric heart transplant recipients.
    Sachdeva R; Seib PM; Burns SA; Fontenot EE; Frazier EA
    Catheter Cardiovasc Interv; 2007 Nov; 70(6):888-92. PubMed ID: 17932887
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stent insertion for malignant superior vena cava syndrome: effectiveness and long-term outcome.
    Niu S; Xu YS; Cheng L; Cao C
    Radiol Med; 2017 Aug; 122(8):633-638. PubMed ID: 28429206
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Endovascular stenting in neoplastic superior vena cava syndrome prior to chemotherapy or radiotherapy.
    Bierdrager E; Lampmann LE; Lohle PN; Schoemaker CM; Schijen JH; Palmen FM; van der Heul C
    Neth J Med; 2005 Jan; 63(1):20-3. PubMed ID: 15719848
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Stenting in obstruction of superior vena cava; clinical experience with the self-expanding endovascular prosthesis].
    Kanzaki M; Sakuraba M; Kuwata H; Ikeda T; Oyama K; Mae M; Murasugi M; Miyano H; Wachi N; Kikkawa T; Aoshima H; Onuki T
    Kyobu Geka; 2004 May; 57(5):347-50; discussion 350-2. PubMed ID: 15151030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.